Evaluation of intralesional 0.2% ciprofloxacin as a treatment for cutaneous leishmaniasis
AbstractAlthough cutaneous leishmaniasis lesions usually heal spontaneously they cause unsightly scarring. This study evaluated a possible new therapy in 38 patients, with 70 lesions, randomly assigned to intralesional injection of ciprofloxacin [0.2%] or intralesional sodium chloride hypertonic solution [7%]. After excluding patients who defaulted on treatment, lesions assigned to sodium chloride treatment [n = 21] were completely healed [with or without scarring] in 76.2% of cases, and, when a scar remained, the scar size was reduced 66.0% compared with the original lesion. Lesions assigned to ciprofloxacin [n = 27] showed an 81.5% healing rate with an average scar size reduction of 68.6%. Intralesional 0.2% ciprofloxacin was as effective as hypertonic saline in the treatment of cutaneous leishmaniasis infection
Al Hamdi, K.I., Awad, A.H. & Moker, H.M. (2010). Evaluation of intralesional 0.2% ciprofloxacin as a treatment for cutaneous leishmaniasis. EMHJ - Eastern Mediterranean Health Journal, 16 (1), 89-93, 2010 http://www.who.int/iris/handle/10665/117823
JournalEMHJ - Eastern Mediterranean Health Journal, 16 (1), 89-93, 2010
MetadataShow full item record
Showing items related by title and MeSH subject.
Control of cutaneous leishmaniasis in Afghanistan: achievements and challenges – Lutte contre la leishmaniose cutanée en Afghanistan: progrès accomplis et défis à relever World Health Organization = Organisation mondiale de la Santé (2018-04-27)
Cutaneous leishmaniasis: control in selected countries of the WHO Eastern Mediterranean and African Regions: report of an interregional network meeting, Casablanca, Morocco, 23–24 June 2014 World Health Organization (WHO/HTM/NTD/IDM/2015.4, 2015)